Brief: Sedana Medical Q3 EBITDA Loss Widens To SEK 25.1 Mln

Sedana Medical AB (publ)

25/10/2022 06:16

Oct 25 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * Q3 NET SALES FOR QUARTER TOTALLED MSEK 26,5 (28,3)
    * Q3 EBITDA TOTALLED MSEK -25,1 (-14,0)
    * OUTLOOK: CONSENUS INDICATES MORE NORMALIZED ICU PATIENT
NUMBERS
FROM EARLY 2023

Source text for Eikon:  ID:nWkr5syS7F 
Further company coverage:  SEDANA.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))